Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma.

Li M, Liu D, Lee D, Kapoor S, Gibson-Corley KN, Quinn TP, Sagastume EA, Mott SL, Walsh SA, Acevedo MR, Johnson FL, Schultz MK.

Mol Pharm. 2019 Jul 31. doi: 10.1021/acs.molpharmaceut.9b00512. [Epub ahead of print]

PMID:
31318566
2.

Osteolytic disease in IL-6 and Myc dependent mouse model of human myeloma.

Sun F, Cheng Y, Walsh SA, Acevedo MR, Jing X, Han SS, Pisano MD, Tomasson MH, Lichtenstein AK, Zhan F, Hari P, Janz S.

Haematologica. 2019 Jun 20. pii: haematol.2019.221127. doi: 10.3324/haematol.2019.221127. [Epub ahead of print]

3.

Strontium-releasing fluorapatite glass-ceramic scaffolds: Structural characterization and in vivo performance.

Denry I, Goudouri OM, Fredericks DC, Akkouch A, Acevedo MR, Holloway JA.

Acta Biomater. 2018 Jul 15;75:463-471. doi: 10.1016/j.actbio.2018.05.047. Epub 2018 May 30.

4.

Demonstration of Nucleoside Transporter Activity in the Nose-to-Brain Distribution of [18F]Fluorothymidine Using PET Imaging.

Ponto LLB, Huang J, Walsh SA, Acevedo MR, Mundt C, Sunderland J, Donovan M.

AAPS J. 2017 Dec 7;20(1):16. doi: 10.1208/s12248-017-0158-5.

5.

FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms.

BonDurant LD, Ameka M, Naber MC, Markan KR, Idiga SO, Acevedo MR, Walsh SA, Ornitz DM, Potthoff MJ.

Cell Metab. 2017 Apr 4;25(4):935-944.e4. doi: 10.1016/j.cmet.2017.03.005.

6.

Musclin is an activity-stimulated myokine that enhances physical endurance.

Subbotina E, Sierra A, Zhu Z, Gao Z, Koganti SR, Reyes S, Stepniak E, Walsh SA, Acevedo MR, Perez-Terzic CM, Hodgson-Zingman DM, Zingman LV.

Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):16042-7. doi: 10.1073/pnas.1514250112. Epub 2015 Dec 14.

7.

Adoptive B-cell transfer mouse model of human myeloma.

Tompkins VS, Rosean TR, Holman CJ, DeHoedt C, Olivier AK, Duncan KM, Jing X, Foor SD, Acevedo MR, Walsh SA, Tricot G, Zhan F, Janz S.

Leukemia. 2016 Apr;30(4):962-6. doi: 10.1038/leu.2015.197. Epub 2015 Jul 23. No abstract available.

8.

Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus.

Morgan DA, McDaniel LN, Yin T, Khan M, Jiang J, Acevedo MR, Walsh SA, Ponto LL, Norris AW, Lutter M, Rahmouni K, Cui H.

Diabetes. 2015 Jun;64(6):1976-87. doi: 10.2337/db14-1257. Epub 2015 Jan 20.

9.

PET/CT imaging reveals unrivaled placental avidity for glucose compared to other tissues.

Sawatzke AB, Norris AW, Spyropoulos F, Walsh SA, Acevedo MR, Hu S, Yao J, Wang C, Sunderland JJ, Boles Ponto LL.

Placenta. 2015 Feb;36(2):115-20. doi: 10.1016/j.placenta.2014.12.009. Epub 2014 Dec 23.

10.

(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.

Duncan K, Rosean TR, Tompkins VS, Olivier A, Sompallae R, Zhan F, Tricot G, Acevedo MR, Ponto LL, Walsh SA, Tygrett LT, Berger AJ, Waldschmidt T, Morse HC 3rd, Sunderland JJ, Janz S.

Blood Cancer J. 2013 Nov 29;3:e165. doi: 10.1038/bcj.2013.61.

Supplemental Content

Loading ...
Support Center